Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in blood

Jelmer Legebeke; Jenny Lord; Rebekah Penrice-Randal; Andres F. Vallejo; Stephen Poole; Nathan J. Brendish; Xiaofeng Dong; Catherine Hartley; John W. Holloway; Jane S. Lucas; Anthony P. Williams; Gabrielle Wheway; Fabio Strazzeri; Aaron Gardner; James P.R. Schofield; Paul J. Skipp; Julian A. Hiscox; Marta E. Polak; Tristan W. Clark; Diana Baralle

doi:10.1101/2021.05.12.21257086

Supplementary figures[supplements/257086_file02.pdf]
Supplemental Data 1[supplements/257086_file03.xlsx]
Additional file 2: Differential gene expression results between patients with COVID-19 or influenza.[supplements/257086_file04.xlsx]
Additional file 3: Gene pathways identified by TopMD topological analysis between patients with COVID-19 or influenza.[supplements/257086_file05.xlsx]
Additional file 4: Differential gene expression results between COVID-19 survivors and non-survivors.[supplements/257086_file06.xlsx]
Additional file 5: Differential splicing results and discussion[supplements/257086_file07.pdf]
Additional file 6: Differential splicing results between patients with COVID-19 or influenza.[supplements/257086_file08.xlsx]